Objective
aMCI, amnestic mild, cognitive impairment
We aim to develop a radiomics model based on 3‐dimensional (3D)‐T1WI images to discriminate amnestic mild cognitive impairment (aMCI) patients from the normal population by measuring changes in frontal white matter.